The global Mesalamine (Lialda) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The USA market for Global Mesalamine (Lialda) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
Download FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/7870726/global-mesalamine-forecast-2023-2030-644
The China market for Global Mesalamine (Lialda) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Mesalamine (Lialda) market is estimated to increase from USD million in 2022 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
An anti-inflammatory agent, structurally related to the salicylates and non-steroidal anti-inflammatory drugs like acetylsalicylic acid, which is active in inflammatory bowel disease?2. It is considered to be the active moiety of sulphasalazine. (From Martindale, The Extra Pharmacopoeia, 30th ed) Although demonstrably effective in treating and maintaining remission for ulcerative colitis, mesalazine has historically faced a number of issues regarding its lack of stability as a pharmaceutical agent.
This report aims to provide a comprehensive presentation of the global market for Mesalamine (Lialda), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalamine (Lialda).
This report contains market size and forecasts of Mesalamine (Lialda) in global, including the following market information:
- Global Mesalamine (Lialda) Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Enemas Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Mesalamine (Lialda) include Dr.Falk Pharma, Ferring, Ethypharm Pharmaceutical, Shanghai Pharmaceutical, Tillotts Pharma, Holy Stone Healthcare, Giuliani, Zeria and Lupin, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Mesalamine (Lialda) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mesalamine (Lialda) Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Mesalamine (Lialda) Market Segment Percentages, by Type, 2022 (%)
- Enemas
- Tablets
- Suppositories
- Other
Global Mesalamine (Lialda) Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Mesalamine (Lialda) Market Segment Percentages, by Application, 2022 (%)
- Colitis
- Crohn's Disease
- Proctitis
- Diarrheal Irritable Bowel Syndrome
- Diverticulitis
- Other
Global Mesalamine (Lialda) Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Mesalamine (Lialda) Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Mesalamine (Lialda) revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Mesalamine (Lialda) revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Dr.Falk Pharma
- Ferring
- Ethypharm Pharmaceutical
- Shanghai Pharmaceutical
- Tillotts Pharma
- Holy Stone Healthcare
- Giuliani
- Zeria
- Lupin
- Heilongjiang Tianhong Pharmaceutical
- HENGCHENG PHARMACEUTICAL
- KWAI FA Pharmaceutical Group
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mesalamine (Lialda), market overview.
Chapter 2: Global Mesalamine (Lialda) market size in revenue.
Chapter 3: Detailed analysis of Mesalamine (Lialda) company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mesalamine (Lialda) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
Get the Complete Report & TOC @ https://www.statsmarketresearch.com/global-mesalamine-forecast-2023-2030-644-7870726
Table of content
1 Introduction to Research & Analysis Reports
1.1 Mesalamine (Lialda) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mesalamine (Lialda) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mesalamine (Lialda) Overall Market Size
2.1 Global Mesalamine (Lialda) Market Size: 2022 VS 2030
2.2 Global Mesalamine (Lialda) Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Mesalamine (Lialda) Players in Global Market
3.2 Top Global Mesalamine (Lialda) Companies Ranked by Revenue
3.3 Global Mesalamine (Lialda) Revenue by Companies
3.4 Top 3 and Top 5 Mesalamine (Lialda) Companies in Global Market, by Revenue in 2022
3.5 Global Companies Mesalamine (Lialda) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Mesalamine (Lialda) Players in Global Market
3.6.1 List of Global Tier 1 Mesalamine (Lialda) Companies
3.6.2 List of Global Tier 2 and Tier 3 Mesalamine (Lialda) Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Mesalamine (
Customize/Section/Part Purchase @ https://www.statsmarketresearch.com/chapters-purchase/7870726/global-mesalamine-forecast-2023-2030-644
CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414
Similar Reports:
Mesalamine (Lialda) Market, Global Outlook and Forecast 2023-2030
Global Mesalamine (Lialda) Market Insights and Forecast to 2028
2022-2027 Global and Regional Mesalamine (Lialda) Industry Status and Prospects Professional Market Research Report Standard Version
Mesalamine (Lialda) Market - Global Outlook and Forecast 2022-2028